Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

NCT01168882 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision to not initiate clinical trial at this time

Conditions

Hematological Malignancies

Interventions

DRUG: RGB-286638

Sponsor

Agennix